Literature DB >> 29509956

Relapse in dermatofibrosarcoma protuberans: A histological and molecular analysis.

André S Molina1, João P Duprat Neto1, Eduardo Bertolli1, Isabela W da Cunha2, José H T G Fregnani3, Pedro H M Figueiredo4, Fernando A Soares2, Mariana P Macedo2, Clovis A Pinto Lopes2, Ivan D de Abranches Oliveira Santos Filho1.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a rare low grade tumor with a locally aggressive behavior and low metastatic potential.
OBJECTIVES: To evaluate the factors that are associated with relapse in DFSP. Methods Retrospective analysis of medical records from 61 patients with dermatofibrosarcoma. Fluorescence in situ hybridization was used to detect translocations.
RESULTS: Of 61 patients, 6 experienced a relapse. No patient with resection margins greater than 3 cm had a recurrence. One relapse was observed in a patient treated with at least 2 cm margins and 4 relapses occurred in 16 patients whose margins were below 2 cm (P = 0.018). The frequency of translocations was 77.8%. The recurrence rate was lower in patients with translocation, but this difference was not significant. Immunohistochemical markers did not correlate with recurrence rates, but greater FasL expression was associated with recurrence in patients with margins smaller than 3 cm.
CONCLUSIONS: Surgical margins smaller than than 2 cm are related to higher recurrences in dermatofibrosarcomas. In this analysis a 2 cm margin was acceptable for treatment. Between all the immunohistochemical markers analyzed, only FasL was associated with a higher recurrence rate in patients with margins smaller than 3 cm.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  dermatofibrosarcoma protuberans; molecular and histological analysis; relapse

Mesh:

Substances:

Year:  2018        PMID: 29509956     DOI: 10.1002/jso.25039

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Dermoscopy of Dermatofibrosarcoma Protuberans: What Do We Know?

Authors:  Gabriela F Escobar; Caroline K Ribeiro; Leandro L Leite; Carolina R Barone; André Cartell
Journal:  Dermatol Pract Concept       Date:  2019-04-30

2.  Clinical Outcome of Dermatofibrosarcoma Protuberance. Report From the Bone and Soft Tissue Tumor (BSTT) Registry in Japan.

Authors:  Tomoki Nakamura; Akira Kawai; Kunihiro Asanuma; Tomohito Hagi; Akihiro Sudo
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.406

3.  Comprehensive analysis of transcriptome characteristics and identification of TLK2 as a potential biomarker in dermatofibrosarcoma protuberans.

Authors:  Xiao Zhang; Di Sun; Haiyan Zheng; Yamin Rao; Yuqi Deng; Xiao Liang; Jun Chen; Jun Yang
Journal:  Front Genet       Date:  2022-09-05       Impact factor: 4.772

4.  Risk factors related to postoperative recurrence of dermatofibrosarcoma protuberans: A retrospective study and literature review.

Authors:  Jian-Xia Xiong; Tao Cai; Li Hu; Xiao-Li Chen; Kun Huang; Ai-Jun Chen; Ping Wang
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

5.  Dermatofibrosarcoma protuberans in a young patient with epidermolysis bullosa: a case report.

Authors:  B Bonaventura; D Kraus; G B Stark; H Fuellgraf; J Kiefer
Journal:  BMC Surg       Date:  2021-02-23       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.